Partex
Sanjee Tawde is an accomplished professional with extensive experience in sales and business development within the pharmaceutical and biotech sectors. Currently serving as Director of Sales and Business Development at Partex NV and Assay.Works since February 2024, Sanjee leads initiatives focused on early-stage drug discovery, particularly small molecules research. Prior roles include Head of Operations & Program Management at Axxam, where responsibilities encompassed business development and project management, and Program Manager at Hit Discovery Constance, managing cross-functional teams. Sanjee's career began as a Senior Research Assistant at Evotec, specializing in high-throughput screening, with foundational roles as a Cell Assay Scientist at AstraZeneca and SATHGEN Therapeutics. Sanjee holds an MBA in Pharmaceutical Marketing and Management, an MSc in Cancer Cell and Molecular Biology, and a BSc in Biomedical Sciences.
This person is not in any teams
This person is not in any offices
Partex
Partex NV is the first digital pharma platform that is set to be the largest AI-powered Drug Assets Manager. With the power of AI at its core, we at Partex NV Group deliver faster, lower-cost healthcare innovations, validated by wet-lab and real-world evidence. Our pioneering digital platform enables smarter decision-making throughout the entire value chain. What sets us apart: - Within the Partex ecosystem, patients keep ownership of their data and they are rewarded for participating in research projects - Our AI/ML algorithms enable key industry players to develop life-saving drugs while also developing our own drug assets - A strong history of success and performance: from humble software beginnings to a fully-fledged platform with over 250 employees in 3 continents Our vision is to transform the Life science Industry by curing incurable diseases and increasing humanity's longevity. We dare to care! We have a global presence that extends from APAC to the Americas, with offices currently in India, Germany, Switzerland and USA. CEO & Co-Founder: Dr. Gunjan Bhardwaj Chairman & Co-Founder: Francisco Fernandez Companies belonging to Partex group: www.innoplexus.com www.cureteq.com www.perpetualblock.io www.amrit.ai www.assay.works